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Protocol
========

1. Generation of dsRNA.
-----------------------

1.  Synthesize oligonucleotide primers containing T7 promoter sequences for *in vitro* transcription and synthesis of dsRNA (for example, for *Dermacentor variabilis* subolesin use oligonucleotide primers D8AAT75: 5\'-TAATACGACTCACTATAGGGTACTGACTGGGATCCCCTGCACAGT-3\' and D8DVT73: 5\'-TAATACGACTCACTATAGGGTACTCGAGCTTGGTGGAAAGGACG-3\').

2.  Amplify target gene by RT-PCR using 10 pmol of each oligonucleotide primer and 1-10 ng of tick total RNA.

3.  Purify the PCR product.

4.  Synthesize dsRNA using 8 μL of the purified PCR product.

5.  Quantify dsRNA by spectrometry.

2. Injection of Ticks with dsRNA.
---------------------------------

2.1. Preparation of ticks for injection.
----------------------------------------

1.  First, wash the ticks in a series of solutions by shaking them in each solution in a 50 mL disposable centrifuge tube, decanting the solution through a fine mesh wire screen over the tube top to retain the ticks. The sequence of the solutions for washing ticks is tap water, 3% hydrogen peroxide, two washes of distilled water, 70% ethanol and two more washes with distilled water.

2.  Blot-dry the ticks on paper towels.

3.  Count the ticks into groups of 20 to 50, depending upon the experiment, place the ticks from each group in a 1.25 oz plastic cup with a tightly fitted lid and label with the experimental group number.

2.2. Tick injection team.
-------------------------

The RNAi team consists of three people: (1) one person who positions each tick on double sticky tape affixed to a sheet of red dental wax, (2) one person who injects the ticks and (3) one person who monitors the ticks after injection, breathes CO~2~ on the ticks to activate them and counts the living ticks into cups labeled with the experimental group number. All team members must wear disposable gloves.

2.3. Placement of ticks for injection.
--------------------------------------

1.  Capture a tick using Dumont fine forceps and place it ventral side up on double sticky tape affixed to a 3\" x 6\" sheet of red dental wax. The ticks are closely positioned together in groups of 5 ticks.

2.  Place a small strip of masking tape over the mouthparts of all 5 ticks in order to further restrain them but while leaving most of the body exposed so that the injection process can be observed by the tick injector (Figure 1).

2.4. Injection of ticks.
------------------------

1.  The ticks will be injected in the lower right quadrant of the ventral surface of the exoskeleton.

2.  First, pierce a hole in the exoskeleton using a Monoject insulin syringe fitted with a ½\", 29 gauge needle (Figure 2a).

3.  Inject ticks immediately with 0.2-0.5 μL of dsRNA solution (5 x 10^10^ - 5 x 10^11^ molecules per μL) using a custom-made Hamilton syringe with a 1 inch, 33 gauge needle with a 45° beveled point (Figure 2b). The needle should be placed well into the tick cavity to insure the placement and retention of the dsRNA. Some fluid is likely to escape from the injection site (Figure 2c). Care should be taken not to over inject the ticks, which would cause loss of hemolymph and could cause the death of the tick.

4.  Clean the Hamilton syringe after completing the injections in each experimental group. before using for another experimental group. Fill the syringe first from a beaker containing 3% hydrogen peroxide and then expel into a waste container, and repeat 15 times. Fill the syringe from a beaker containing sterile water and then expel into a waste container, and repeat 15 times. Take care not to bend the plunger of the Hamilton syringe because, if bent, the plunger will not move smoothly and respond to the gentle touch required for injection of ticks.

2.5. Treatment of ticks after injection.
----------------------------------------

1.  Pick up the injected tick immediately from the double sticky tape with the fine forceps and place it in a plastic recovery container (approximately 6\" x 6\" and ringed with masking tape to prevent escape of the ticks). The ticks will be briefly inactive after injection but should soon begin to crawl around the dish.

2.  Breath CO~2~ onto the ticks immediately after placing them in the recovery container to help activate the ticks. Once the ticks are crawling and active, the injection wound will heal rapidly and they will most likely survive.

3.  Count the ticks according to the number in each experimental group and place them in a labeled plastic cup with a tightly fitted lid. Replacement ticks should be injected to replace any that any died before injecting the next experimental group.

2.6. Tick holding.
------------------

1.  Place the ticks in a humidity chamber (12hr light: 12 hr dark photoperiod at 22-25°C and 95% relative humidity) and hold for 1 day.

2.  Place ticks in tick-feeding cells, one per experimental group, glued to a sheep and allow them to feed with an equal number of uninjected male or female ticks (whichever sex was not injected). Female ticks that feed to repletion, those that are removed from the sheep after 10 days of feeding or when the control females have dropped off the host are collected and weighed.

3.  Place the ticks in cartons, and hold in the humidity chamber until completion of oviposition. Evaluate oviposition by weighting the egg mass produced by all ticks in the group.

2.7. Analysis of tick phenotype after RNAi.
-------------------------------------------

1.  Evaluate tick phenotype after feeding by determining the number of ticks that survived, tick weight, oviposition and egg fertility. However, other analyses may be performed depending on the targeted gene and objectives of the study.

3. Analysis to Confirm Gene Silencing by RT-PCR.
------------------------------------------------

1.  Dissect salivary glands and guts from individual ticks from control-injected and dsRNA-injected groups after feeding.

2.  Extract total RNA from individual tissue samples.

3.  Analyze target gene transcripts in individual tissues by real-time RT-PCR and normalize RNA levels against tick 16S rRNA using the genNorm method (ddCT method as implemented by Bio-Rad iQ5 Standard Edition, Version 2.0).

4.  Run dissociation curves at the end of the reaction to ensure that only one amplicon is formed and that the amplicons denature consistently in the same temperature range for every sample.

5.  Compare mRNA levels (normalized Ct values) between control-injected and dsRNA-injected ticks using the Student\`s t-test (P=0.05).

4. Representative Results:
--------------------------

The protocol described herein has been used in our laboratory for RNAi in many different ixodid tick species (Table 1). The amount of dsRNA injected into the ticks varies with the size of the tick; larger tick species can accommodate a larger volume. Negative control ticks should be injected with an unrelated dsRNA. Several dsRNAs such as subolesin^14-19,22-25,27-32,34^ and beta-actin^20,21^ could be used as positive controls. Note that it is important to wash the syringe between treatments to avoid mixing dsRNA solutions. If the protocol is done correctly, less than 5% mortality should be obtained from the injection procedure after 24 hours. A typical phenotype after gene knockdown in ticks is shown in Figure 3 with a panel of ticks injected with pools of dsRNA in order to screen for tick protective antigens.

  ---------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------
  **Tick species**             **dsRNA injected**                                                                                                                                                         **References**
  *Ixodes scapularis*          cDNA library, subolesin, actin, nucleotidase, NF-kB, akirin                                                                                                                21, 22, 29, 30
  *Dermacentor variabilis*     subolesin, GST, ubiquitin, vATPase, selenoproteins M and W2a, hematopoietic stem/progenitor cells protein-like, actin Proteasome 26S subunit, ferritin1, varisin, akirin   15, 19, 22, 24, 26, 30-32
  *Dermacentor marginatus*     subolesin                                                                                                                                                                  22
  *Amblyomma americanum*       cDNA library, subolesin, akirin                                                                                                                                            17, 22, 30
  *Amblyomma hebraeum*         subolesin, voraxin                                                                                                                                                         28
  *Rhipicephalus sanguineus*   Rs86, subolesin                                                                                                                                                            22, 23
  *Rhipicephalus microplus*    GST, ubiquitin, selenoprotein, Bm86, Bm91, subolesin, GI, GIII, EF1a, flagelliform silk protein, von Willebrand factor                                                     16, 18, 25, 27
  *Rhipicephalus annulatus*    ubiquitin, subolesin, EF1a, GIII                                                                                                                                           16
  ---------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------

**Table 1.**Tick species in which the RNAi protocol has been used.

**Figure 1.** Placement of ticks, ventral side up, on double sticky tape adhered to a sheet of red dental wax. The ticks are placed in groups of 5, after which a small strip of masking tape is placed over the mouthparts in order to further secure the ticks while allowing the injector to observe the body of the tick during injection.

**Figure 2.** The injection procedure includes (a) piercing the lower right quadrant of the tick exoskeleton with a insulin syringe fitted with a 29 gauge needle in order to create an injection site, (b) immediate injection of the dsRNA at this site using a Hamilton syringe with a 33 gauge needle which (c) most likely will result in some leakage of tick hemolymph/fluids.

**Figure 3.** A panel of tick six groups in which RNAi was used to screen for tick protective antigens in Amblyomma americanum. The phenotypic changes in ticks can be seen when compared with the positive subolesin RNAi control and the negative unrelated dsRNA control. In this experiment the effect of RNAi on tick mortality, weights, and oviposition of each group was statistically analyzed.

Discussion
==========

Although other methods have been described for RNAi in ticks^14,\ 33^, the injection of dsRNA described here is the most widely used in both unfed (Table 1) and fed ticks^16,25,34^. RNAi has been shown to be a valuable tool for the study of tick gene function, the characterization of the tick-pathogen interface and the screening and characterization of tick protective antigens^14,35^. In particular, RNAi has become the most valuable tool for functional analyses in ticks^35^.

Methodologically, RNAi will likely evolve into more efficient methods that may allow gene knockdown in a large number of individuals. The mechanism of dsRNA-induced RNAi in ticks should be refined to contribute to a better understanding and utilization of this genetic approach in this species^35,36^. The extent of off-target effects of RNAi in ticks is also an important question that needs to be fully addressed^14,27^. Finally, RNAi will most likely provide comprehensive contributions to the study of tick gene regulation and systems biology and the tick-pathogen interface and may have an impact on the development of vaccines to control tick infestations and the transmission of tick-borne pathogens.
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